Study: Pattanittum 2021, Cochrane Database of Systematic Reviews

Roselle for hypertension in adults

Citation

Pattanittum P, Ngamjarus C, Buttramee F, Somboonporn C (2021). Cochrane Database of Systematic Reviews. PubMed id 34837382.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Hibiscus (sorrel, zobo, bissap) and blood pressure Tier A thin

    B Adults with high blood pressure; strict Cochrane criteria (n=52)

    Cochrane review of randomised trials of roselle against placebo or no treatment, searched to August 2021.

    Only one trial met the criteria (60 people with type 2 diabetes, 8 weeks, capsules). Effect on systolic pressure was 1.65 mmHg (95% CI -7.89 to 11.19), very low certainty. The review concludes evidence is insufficient to say whether roselle lowers blood pressure.

    As recorded in this card: Pattanittum P, Ngamjarus C, Buttramee F, Somboonporn C (2021), Cochrane Database of Systematic Reviews, [review]

    Note: Counter-evidence. Cochrane's inclusion rules were narrower than the 2025 umbrella review, which is why they disagree.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.